Collectively, our study provides new insights into SDC4 as a previously undisclosed promising therapeutic target against HCC, and SDC4/DDX23 signaling axis plays a fundamental role in suppressing HCC growth and progression. This evidence concerns the gene DDX23 and hepatocellular carcinoma.